比亞迪(01211.HK)歐洲特別顧問:未來在歐洲擴產 需在當地生產電池
《路透》報道,比亞迪(01211.HK)歐洲特別顧問Alfredo Altavilla表示,公司未來數年將擴大歐洲汽車生產,將需在歐洲生產汽車電池,並指僅投資汽車組裝廠且要從中國運來電池並不合乎邏輯。
他指公司仍要決定優先興建區內第三間組裝廠或建立電池廠,又指公司在進一步投資歐洲時正考慮所有國家,同時與各地政府互動。
比亞迪目前在匈牙利興建廠房料於年內投產。位於土耳其的廠房料於明年投產,兩間廠房年產能共50萬輛。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.